Global Prenatal Genetic Testing — Forecast to 2026
New technological advances in prenatal genetic testing include the enhancement of the next-generation sequencing (NGS) technology, chromosomal microarray analysis (CMA) tool, and PCR TaqMan. These improve precision and specificity in genome profiling, augment the efficiency and reliability of testing, and streamline workflow.
The study will help prenatal genetic testing providers understand the key trends emerging in the market (for the various prenatal tests offered in different geographic regions). It provides information on the state of the market and estimates its growth for the next 5 years, and it lists the unmet needs that companies must work on for their continuous growth. In addition, the study provides an overview of the major vendors offering tests, their market concentration, and different growth strategies.
The above deliverable is the latest addition to Frost & Sullivan’s Healthcare research and analyses, available through the Frost & Sullivan Growth Partnership Services, which help organizations identify a continuous flow of growth opportunities to succeed in an unpredictable future.
Sign up for a complimentary Growth Pipeline Dialog™
A Growth Pipeline Dialog is a structured open discussion with our growth experts providing unparalleled market intelligence, technology insights, and proven implementation best practices. This discussion will spark innovative thinking and help generate a pipeline of growth opportunities you can leverage to maximize your company’s future growth potential.